

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * cellular response to type I interferon (GO:0071357) | 5.93707589 |
| 2 | * type I interferon signaling pathway (GO:0060337) | 5.93707589 |
| 3 | * response to type I interferon (GO:0034340) | 5.90990513 |
| 4 | cellular response to interferon-alpha (GO:0035457) | 5.53167363 |
| 5 | response to interferon-alpha (GO:0035455) | 5.27352794 |
| 6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.18434720 |
| 7 | regulation of activation of Janus kinase activity (GO:0010533) | 5.17903389 |
| 8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.12627953 |
| 9 | regulation of RIG-I signaling pathway (GO:0039535) | 5.11290489 |
| 10 | positive regulation of interferon-alpha production (GO:0032727) | 5.10326252 |
| 11 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.98787657 |
| 12 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.92352528 |
| 13 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.92352528 |
| 14 | regulation of interferon-alpha production (GO:0032647) | 4.78909850 |
| 15 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.77130341 |
| 16 | negative regulation of viral genome replication (GO:0045071) | 4.75101514 |
| 17 | positive regulation of natural killer cell differentiation (GO:0032825) | 4.69037083 |
| 18 | regulation of chronic inflammatory response (GO:0002676) | 4.67729803 |
| 19 | T-helper 1 type immune response (GO:0042088) | 4.48588144 |
| 20 | neutrophil activation involved in immune response (GO:0002283) | 4.42207453 |
| 21 | regulation of viral genome replication (GO:0045069) | 4.40056005 |
| 22 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.36966660 |
| 23 | cellular response to interferon-beta (GO:0035458) | 4.35833817 |
| 24 | negative regulation of interleukin-12 production (GO:0032695) | 4.34370235 |
| 25 | * regulation of type I interferon-mediated signaling pathway (GO:0060338) | 4.30401617 |
| 26 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 4.28487905 |
| 27 | interferon-gamma-mediated signaling pathway (GO:0060333) | 4.27437409 |
| 28 | negative regulation of viral process (GO:0048525) | 4.25839165 |
| 29 | cellular response to exogenous dsRNA (GO:0071360) | 4.21674972 |
| 30 | positive regulation of type 2 immune response (GO:0002830) | 4.21273019 |
| 31 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 4.17366534 |
| 32 | positive regulation of interleukin-17 production (GO:0032740) | 4.14178326 |
| 33 | immunoglobulin mediated immune response (GO:0016064) | 4.12401353 |
| 34 | response to peptidoglycan (GO:0032494) | 4.10012351 |
| 35 | macrophage activation involved in immune response (GO:0002281) | 4.09288290 |
| 36 | positive regulation of interleukin-12 production (GO:0032735) | 4.04904598 |
| 37 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 4.02522591 |
| 38 | positive regulation of antigen processing and presentation (GO:0002579) | 4.01654736 |
| 39 | positive regulation of T-helper cell differentiation (GO:0045624) | 4.01408391 |
| 40 | response to interferon-beta (GO:0035456) | 4.00281968 |
| 41 | defense response to protozoan (GO:0042832) | 3.99059523 |
| 42 | natural killer cell mediated immunity (GO:0002228) | 3.98073385 |
| 43 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.98073385 |
| 44 | negative regulation of interleukin-17 production (GO:0032700) | 3.96361074 |
| 45 | regulation of vitamin metabolic process (GO:0030656) | 3.96085176 |
| 46 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.88340976 |
| 47 | regulation of MHC class I biosynthetic process (GO:0045343) | 3.87226944 |
| 48 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.83150169 |
| 49 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.74794674 |
| 50 | regulation of interleukin-17 production (GO:0032660) | 3.73806454 |
| 51 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.73612196 |
| 52 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.71261628 |
| 53 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.69892683 |
| 54 | regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139) | 3.68670832 |
| 55 | positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141) | 3.68670832 |
| 56 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.65463717 |
| 57 | positive regulation of defense response to virus by host (GO:0002230) | 3.61076484 |
| 58 | regulation of memory T cell differentiation (GO:0043380) | 3.57236773 |
| 59 | granulocyte activation (GO:0036230) | 3.57046234 |
| 60 | positive regulation by symbiont of host defense response (GO:0052509) | 3.55713082 |
| 61 | modulation by symbiont of host defense response (GO:0052031) | 3.55713082 |
| 62 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.55713082 |
| 63 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.55713082 |
| 64 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.55713082 |
| 65 | modulation by symbiont of host immune response (GO:0052553) | 3.55713082 |
| 66 | cellular response to interferon-gamma (GO:0071346) | 3.54280508 |
| 67 | cellular response to virus (GO:0098586) | 3.53658124 |
| 68 | positive regulation of interferon-beta production (GO:0032728) | 3.53639370 |
| 69 | defense response to virus (GO:0051607) | 3.53590765 |
| 70 | regulation of type 2 immune response (GO:0002828) | 3.52782879 |
| 71 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.52592077 |
| 72 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.51241501 |
| 73 | regulation of antigen processing and presentation (GO:0002577) | 3.50329505 |
| 74 | T cell migration (GO:0072678) | 3.49207847 |
| 75 | positive regulation of humoral immune response (GO:0002922) | 3.48583613 |
| 76 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.47352184 |
| 77 | neutrophil activation (GO:0042119) | 3.46033493 |
| 78 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.44732127 |
| 79 | regulation of chemokine biosynthetic process (GO:0045073) | 3.43161161 |
| 80 | regulation of defense response to virus by host (GO:0050691) | 3.42806650 |
| 81 | NIK/NF-kappaB signaling (GO:0038061) | 3.41301410 |
| 82 | myeloid dendritic cell differentiation (GO:0043011) | 3.41133589 |
| 83 | B cell mediated immunity (GO:0019724) | 3.39667656 |
| 84 | response to protozoan (GO:0001562) | 3.37062976 |
| 85 | regulation of T-helper cell differentiation (GO:0045622) | 3.36786523 |
| 86 | cellular response to zinc ion (GO:0071294) | 3.36648634 |
| 87 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.32685512 |
| 88 | positive regulation of response to biotic stimulus (GO:0002833) | 3.31949872 |
| 89 | eosinophil chemotaxis (GO:0048245) | 3.31877527 |
| 90 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.31686711 |
| 91 | response to interferon-gamma (GO:0034341) | 3.30933892 |
| 92 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.30213609 |
| 93 | natural killer cell activation involved in immune response (GO:0002323) | 3.29910498 |
| 94 | negative regulation of type I interferon production (GO:0032480) | 3.29318657 |
| 95 | regulation of immunoglobulin secretion (GO:0051023) | 3.29171593 |
| 96 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.28656844 |
| 97 | regulation of natural killer cell differentiation (GO:0032823) | 3.27317769 |
| 98 | lymphocyte chemotaxis (GO:0048247) | 3.25581872 |
| 99 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.24747100 |
| 100 | negative thymic T cell selection (GO:0045060) | 3.24040734 |
| 101 | natural killer cell activation (GO:0030101) | 3.23745609 |
| 102 | regulation of podosome assembly (GO:0071801) | 3.22573915 |
| 103 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.21483063 |
| 104 | regulation of tyrosine phosphorylation of Stat1 protein (GO:0042510) | 3.20686668 |
| 105 | monocyte chemotaxis (GO:0002548) | 3.20228765 |
| 106 | regulation of T-helper 1 type immune response (GO:0002825) | 3.18294079 |
| 107 | positive regulation of heat generation (GO:0031652) | 3.18282339 |
| 108 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.17290324 |
| 109 | modulation by symbiont of host cellular process (GO:0044068) | 3.16150707 |
| 110 | regulation of hypersensitivity (GO:0002883) | 3.15762503 |
| 111 | myeloid dendritic cell activation (GO:0001773) | 3.15587255 |
| 112 | regulation of fever generation (GO:0031620) | 3.15006052 |
| 113 | response to exogenous dsRNA (GO:0043330) | 3.14774465 |
| 114 | negative regulation of T cell mediated immunity (GO:0002710) | 3.14319256 |
| 115 | negative T cell selection (GO:0043383) | 3.13919763 |
| 116 | regulation of response to interferon-gamma (GO:0060330) | 3.10568288 |
| 117 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.10531370 |
| 118 | regulation of interleukin-12 production (GO:0032655) | 3.09977415 |
| 119 | negative regulation of defense response to virus (GO:0050687) | 3.08942813 |
| 120 | negative regulation of viral entry into host cell (GO:0046597) | 3.08369913 |
| 121 | regulation of interferon-beta production (GO:0032648) | 3.07771220 |
| 122 | negative regulation of viral release from host cell (GO:1902187) | 3.06893601 |
| 123 | regulation of T cell tolerance induction (GO:0002664) | 3.06437623 |
| 124 | positive regulation of T-helper 1 type immune response (GO:0002827) | 3.06152743 |
| 125 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.05375712 |
| 126 | regulation of natural killer cell activation (GO:0032814) | 3.02729587 |
| 127 | positive regulation of isotype switching (GO:0045830) | 3.01422188 |
| 128 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.01320817 |
| 129 | response to host immune response (GO:0052572) | 3.01320817 |
| 130 | interferon-gamma secretion (GO:0072643) | 3.00279045 |
| 131 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.99859318 |
| 132 | germinal center formation (GO:0002467) | 2.99438599 |
| 133 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.98314845 |
| 134 | negative regulation of multi-organism process (GO:0043901) | 2.96364062 |
| 135 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.94125880 |
| 136 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.92370741 |
| 137 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.91070781 |
| 138 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.91045300 |
| 139 | dendritic cell differentiation (GO:0097028) | 2.90977354 |
| 140 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.86446677 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 9.41603847 |
| 2 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 7.01788877 |
| 3 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.90928458 |
| 4 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 6.15861772 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.30351204 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.55448383 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.89164785 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.48163734 |
| 9 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.40743028 |
| 10 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.21791015 |
| 11 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.14601634 |
| 12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.09320481 |
| 13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.06460866 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.92050457 |
| 15 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.64494329 |
| 16 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.38874769 |
| 17 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.34498305 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 2.24320586 |
| 19 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.10500714 |
| 20 | MYB_26560356_Chip-Seq_TH2_Human | 1.92837688 |
| 21 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.87883848 |
| 22 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.80323999 |
| 23 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.70483793 |
| 24 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.63547711 |
| 25 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.58281019 |
| 26 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.55509521 |
| 27 | MAF_26560356_Chip-Seq_TH1_Human | 1.54751283 |
| 28 | MYB_26560356_Chip-Seq_TH1_Human | 1.54577606 |
| 29 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.54571619 |
| 30 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.53288403 |
| 31 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.46285414 |
| 32 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.43513468 |
| 33 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.43494331 |
| 34 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.35367120 |
| 35 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.35190845 |
| 36 | GATA3_26560356_Chip-Seq_TH2_Human | 1.31442262 |
| 37 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.31188749 |
| 38 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.29077870 |
| 39 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.27829435 |
| 40 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.27624845 |
| 41 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26984166 |
| 42 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.25358338 |
| 43 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.20897136 |
| 44 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19402453 |
| 45 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.19323404 |
| 46 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18827291 |
| 47 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.17981013 |
| 48 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17924810 |
| 49 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16508784 |
| 50 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.16026083 |
| 51 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.15708650 |
| 52 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14007287 |
| 53 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13652774 |
| 54 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.13007322 |
| 55 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.10820440 |
| 56 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.10690861 |
| 57 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.08068250 |
| 58 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.06976094 |
| 59 | SPI1_23127762_ChIP-Seq_K562_Human | 1.03975079 |
| 60 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.03861343 |
| 61 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.02718212 |
| 62 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.98968667 |
| 63 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.98460270 |
| 64 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.97560504 |
| 65 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97507741 |
| 66 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.97495744 |
| 67 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.97312382 |
| 68 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97173816 |
| 69 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.96207771 |
| 70 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.96139549 |
| 71 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92663702 |
| 72 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.92080146 |
| 73 | MYC_22102868_ChIP-Seq_BL_Human | 0.91619439 |
| 74 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91097015 |
| 75 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.89579792 |
| 76 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.87970253 |
| 77 | MAF_26560356_Chip-Seq_TH2_Human | 0.87002937 |
| 78 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.86580376 |
| 79 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.86052228 |
| 80 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.85211403 |
| 81 | UTX_26944678_Chip-Seq_JUKART_Human | 0.85195651 |
| 82 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.83902416 |
| 83 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.83240617 |
| 84 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82965402 |
| 85 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.82912025 |
| 86 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.81952665 |
| 87 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.81621703 |
| 88 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.79697549 |
| 89 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.77348720 |
| 90 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.77284463 |
| 91 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.76543999 |
| 92 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.75420016 |
| 93 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.75140009 |
| 94 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.73856485 |
| 95 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.73249947 |
| 96 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.72877018 |
| 97 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.72813325 |
| 98 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.71934860 |
| 99 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.71595820 |
| 100 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.66449777 |
| 101 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.63633306 |
| 102 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.62424559 |
| 103 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.61334605 |
| 104 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.60749085 |
| 105 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.60749085 |
| 106 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.60538465 |
| 107 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.60506461 |
| 108 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.59468765 |
| 109 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.59120675 |
| 110 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.58858504 |
| 111 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.58553821 |
| 112 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.58346723 |
| 113 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.57226617 |
| 114 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.56254221 |
| 115 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.53870077 |
| 116 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.53831644 |
| 117 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.53831644 |
| 118 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.50295133 |
| 119 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.50272278 |
| 120 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.49550242 |
| 121 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.49382987 |
| 122 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.49254942 |
| 123 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.48772043 |
| 124 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.48569878 |
| 125 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.47993941 |
| 126 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.47556464 |
| 127 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.46586705 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.52001630 |
| 2 | * MP0009785_altered_susceptibility_to | 4.69016161 |
| 3 | MP0002148_abnormal_hypersensitivity_rea | 4.02477925 |
| 4 | MP0000685_abnormal_immune_system | 3.91419135 |
| 5 | MP0005671_abnormal_response_to | 3.84519716 |
| 6 | MP0003724_increased_susceptibility_to | 3.61471405 |
| 7 | MP0006082_CNS_inflammation | 3.41570711 |
| 8 | MP0001790_abnormal_immune_system | 3.34379570 |
| 9 | MP0005387_immune_system_phenotype | 3.34379570 |
| 10 | MP0005000_abnormal_immune_tolerance | 3.29923281 |
| 11 | MP0003436_decreased_susceptibility_to | 3.28327216 |
| 12 | * MP0005025_abnormal_response_to | 3.26042497 |
| 13 | MP0002419_abnormal_innate_immunity | 2.76407266 |
| 14 | MP0001800_abnormal_humoral_immune | 2.75676959 |
| 15 | * MP0002723_abnormal_immune_serum | 2.70009866 |
| 16 | MP0004510_myositis | 2.62270615 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.61542833 |
| 18 | MP0002139_abnormal_hepatobiliary_system | 2.45176877 |
| 19 | MP0001819_abnormal_immune_cell | 2.35734466 |
| 20 | MP0002420_abnormal_adaptive_immunity | 2.30444740 |
| 21 | MP0002006_tumorigenesis | 2.25869924 |
| 22 | MP0002166_altered_tumor_susceptibility | 2.12700101 |
| 23 | MP0009764_decreased_sensitivity_to | 2.06724812 |
| 24 | MP0003763_abnormal_thymus_physiology | 1.97922065 |
| 25 | MP0001348_abnormal_lacrimal_gland | 1.96487708 |
| 26 | MP0004947_skin_inflammation | 1.95944751 |
| 27 | MP0005310_abnormal_salivary_gland | 1.95512647 |
| 28 | MP0002163_abnormal_gland_morphology | 1.91596905 |
| 29 | MP0002405_respiratory_system_inflammati | 1.87924043 |
| 30 | MP0003303_peritoneal_inflammation | 1.86973395 |
| 31 | MP0010155_abnormal_intestine_physiology | 1.85765049 |
| 32 | MP0001533_abnormal_skeleton_physiology | 1.84988785 |
| 33 | MP0005451_abnormal_body_composition | 1.84060483 |
| 34 | * MP0001845_abnormal_inflammatory_respons | 1.83218576 |
| 35 | MP0002138_abnormal_hepatobiliary_system | 1.80845750 |
| 36 | * MP0008469_abnormal_protein_level | 1.79767382 |
| 37 | MP0002254_reproductive_system_inflammat | 1.78589647 |
| 38 | MP0009333_abnormal_splenocyte_physiolog | 1.78402586 |
| 39 | * MP0000716_abnormal_immune_system | 1.75064926 |
| 40 | MP0001853_heart_inflammation | 1.73777470 |
| 41 | MP0003806_abnormal_nucleotide_metabolis | 1.72736453 |
| 42 | MP0003448_altered_tumor_morphology | 1.68136183 |
| 43 | * MP0002398_abnormal_bone_marrow | 1.67179409 |
| 44 | MP0002332_abnormal_exercise_endurance | 1.59634429 |
| 45 | MP0006054_spinal_hemorrhage | 1.57059664 |
| 46 | MP0005464_abnormal_platelet_physiology | 1.55545870 |
| 47 | MP0001346_abnormal_lacrimal_gland | 1.51339782 |
| 48 | MP0005058_abnormal_lysosome_morphology | 1.45963249 |
| 49 | MP0004782_abnormal_surfactant_physiolog | 1.39069184 |
| 50 | * MP0002429_abnormal_blood_cell | 1.35836830 |
| 51 | MP0000858_altered_metastatic_potential | 1.34005455 |
| 52 | MP0003186_abnormal_redox_activity | 1.33191321 |
| 53 | MP0002277_abnormal_respiratory_mucosa | 1.26605106 |
| 54 | MP0002722_abnormal_immune_system | 1.24323403 |
| 55 | MP0008004_abnormal_stomach_pH | 1.24108636 |
| 56 | MP0000689_abnormal_spleen_morphology | 1.22813312 |
| 57 | MP0003191_abnormal_cellular_cholesterol | 1.21628496 |
| 58 | MP0001873_stomach_inflammation | 1.21478096 |
| 59 | MP0002998_abnormal_bone_remodeling | 1.16749271 |
| 60 | MP0003075_altered_response_to | 1.12683302 |
| 61 | MP0009763_increased_sensitivity_to | 1.11077493 |
| 62 | MP0001545_abnormal_hematopoietic_system | 1.08900967 |
| 63 | MP0005397_hematopoietic_system_phenotyp | 1.08900967 |
| 64 | MP0003172_abnormal_lysosome_physiology | 1.08759010 |
| 65 | MP0000343_altered_response_to | 1.08462313 |
| 66 | MP0005379_endocrine/exocrine_gland_phen | 1.04921896 |
| 67 | MP0010307_abnormal_tumor_latency | 0.92661318 |
| 68 | MP0005166_decreased_susceptibility_to | 0.92190728 |
| 69 | MP0003690_abnormal_glial_cell | 0.88320480 |
| 70 | MP0009840_abnormal_foam_cell | 0.86465648 |
| 71 | MP0003045_fibrosis | 0.82527918 |
| 72 | MP0001881_abnormal_mammary_gland | 0.82380224 |
| 73 | MP0010386_abnormal_urinary_bladder | 0.82254190 |
| 74 | MP0000703_abnormal_thymus_morphology | 0.82117788 |
| 75 | MP0005390_skeleton_phenotype | 0.82107641 |
| 76 | MP0003656_abnormal_erythrocyte_physiolo | 0.80918757 |
| 77 | MP0009278_abnormal_bone_marrow | 0.80427506 |
| 78 | MP0002876_abnormal_thyroid_physiology | 0.76308771 |
| 79 | MP0002693_abnormal_pancreas_physiology | 0.75725478 |
| 80 | MP0005165_increased_susceptibility_to | 0.72530667 |
| 81 | MP0005164_abnormal_response_to | 0.70811117 |
| 82 | MP0000920_abnormal_myelination | 0.67762399 |
| 83 | MP0001542_abnormal_bone_strength | 0.66975818 |
| 84 | MP0003453_abnormal_keratinocyte_physiol | 0.66619876 |
| 85 | MP0002933_joint_inflammation | 0.65594226 |
| 86 | MP0000604_amyloidosis | 0.64559247 |
| 87 | MP0005167_abnormal_blood-brain_barrier | 0.64366385 |
| 88 | MP0003195_calcinosis | 0.64294913 |
| 89 | MP0001727_abnormal_embryo_implantation | 0.63920173 |
| 90 | MP0003091_abnormal_cell_migration | 0.63805285 |
| 91 | MP0009765_abnormal_xenobiotic_induced | 0.62627549 |
| 92 | MP0005647_abnormal_sex_gland | 0.62422789 |
| 93 | MP0001851_eye_inflammation | 0.62191571 |
| 94 | MP0008874_decreased_physiological_sensi | 0.62000330 |
| 95 | MP0002136_abnormal_kidney_physiology | 0.61181983 |
| 96 | MP0003866_abnormal_defecation | 0.61146970 |
| 97 | MP0005023_abnormal_wound_healing | 0.60622789 |
| 98 | MP0005266_abnormal_metabolism | 0.59854701 |
| 99 | MP0000249_abnormal_blood_vessel | 0.56460390 |
| 100 | MP0000569_abnormal_digit_pigmentation | 0.56246085 |
| 101 | MP0001663_abnormal_digestive_system | 0.55873123 |
| 102 | MP0005666_abnormal_adipose_tissue | 0.54617721 |
| 103 | MP0002877_abnormal_melanocyte_morpholog | 0.53424236 |
| 104 | MP0000627_abnormal_mammary_gland | 0.50607056 |
| 105 | MP0008057_abnormal_DNA_replication | 0.50339346 |
| 106 | MP0004808_abnormal_hematopoietic_stem | 0.48170422 |
| 107 | MP0000371_diluted_coat_color | 0.47691623 |
| 108 | MP0003300_gastrointestinal_ulcer | 0.46806809 |
| 109 | MP0003183_abnormal_peptide_metabolism | 0.46650219 |
| 110 | MP0002019_abnormal_tumor_incidence | 0.46272845 |
| 111 | MP0003566_abnormal_cell_adhesion | 0.45260823 |
| 112 | MP0009643_abnormal_urine_homeostasis | 0.43941618 |
| 113 | MP0003795_abnormal_bone_structure | 0.43693030 |
| 114 | MP0005319_abnormal_enzyme/_coenzyme | 0.43193296 |
| 115 | MP0005076_abnormal_cell_differentiation | 0.41966080 |
| 116 | MP0000609_abnormal_liver_physiology | 0.39659729 |
| 117 | MP0005408_hypopigmentation | 0.37018598 |
| 118 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.36819275 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased IgM level (HP:0003496) | 6.72665831 |
| 2 | Eczematoid dermatitis (HP:0000976) | 6.08035548 |
| 3 | Recurrent abscess formation (HP:0002722) | 5.92845068 |
| 4 | Autoimmune thrombocytopenia (HP:0001973) | 5.63212431 |
| 5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.57331540 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 5.50601313 |
| 7 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.95610150 |
| 8 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.95610150 |
| 9 | Abnormality of glycolipid metabolism (HP:0010969) | 4.95610150 |
| 10 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.56521784 |
| 11 | Mediastinal lymphadenopathy (HP:0100721) | 4.49019629 |
| 12 | Gastrointestinal infarctions (HP:0005244) | 4.42346759 |
| 13 | Vasculitis (HP:0002633) | 4.32554831 |
| 14 | Abnormality of T cell number (HP:0011839) | 4.31053574 |
| 15 | Abnormality of macrophages (HP:0004311) | 4.25683095 |
| 16 | Autoimmune hemolytic anemia (HP:0001890) | 4.24935733 |
| 17 | Basal ganglia calcification (HP:0002135) | 4.20825152 |
| 18 | Recurrent fungal infections (HP:0002841) | 4.19779233 |
| 19 | Myositis (HP:0100614) | 4.16442670 |
| 20 | Hypergammaglobulinemia (HP:0010702) | 4.11807645 |
| 21 | Recurrent skin infections (HP:0001581) | 4.07571807 |
| 22 | Chronic otitis media (HP:0000389) | 4.07551280 |
| 23 | Orchitis (HP:0100796) | 4.01206838 |
| 24 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.99492381 |
| 25 | Recurrent cutaneous fungal infections (HP:0011370) | 3.99492381 |
| 26 | Recurrent viral infections (HP:0004429) | 3.93460605 |
| 27 | Retrobulbar optic neuritis (HP:0100654) | 3.91565117 |
| 28 | Optic neuritis (HP:0100653) | 3.91565117 |
| 29 | Loss of speech (HP:0002371) | 3.81093464 |
| 30 | Disinhibition (HP:0000734) | 3.73162748 |
| 31 | T lymphocytopenia (HP:0005403) | 3.69653216 |
| 32 | Stomatitis (HP:0010280) | 3.50535448 |
| 33 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.44774190 |
| 34 | Gingivitis (HP:0000230) | 3.44213149 |
| 35 | Tetraparesis (HP:0002273) | 3.42565558 |
| 36 | Systemic lupus erythematosus (HP:0002725) | 3.40082481 |
| 37 | Agnosia (HP:0010524) | 3.38316420 |
| 38 | Recurrent bronchitis (HP:0002837) | 3.35029764 |
| 39 | Abnormality of T cells (HP:0002843) | 3.11344059 |
| 40 | Pulmonary infiltrates (HP:0002113) | 3.11129897 |
| 41 | Interstitial pulmonary disease (HP:0006530) | 3.08897501 |
| 42 | Chronic obstructive pulmonary disease (HP:0006510) | 3.05477249 |
| 43 | Obstructive lung disease (HP:0006536) | 3.05477249 |
| 44 | Nasal polyposis (HP:0100582) | 3.01474206 |
| 45 | Axonal loss (HP:0003447) | 3.01147654 |
| 46 | Periodontitis (HP:0000704) | 2.99276053 |
| 47 | Vacuolated lymphocytes (HP:0001922) | 2.99171422 |
| 48 | Leukocytosis (HP:0001974) | 2.95270372 |
| 49 | Hemoptysis (HP:0002105) | 2.94851397 |
| 50 | Dysostosis multiplex (HP:0000943) | 2.93008310 |
| 51 | Joint swelling (HP:0001386) | 2.92819555 |
| 52 | Pustule (HP:0200039) | 2.91134676 |
| 53 | Eosinophilia (HP:0001880) | 2.90804800 |
| 54 | Porencephaly (HP:0002132) | 2.84329201 |
| 55 | Gingival bleeding (HP:0000225) | 2.79792355 |
| 56 | IgG deficiency (HP:0004315) | 2.78915442 |
| 57 | Abnormality of eosinophils (HP:0001879) | 2.78084083 |
| 58 | Chronic diarrhea (HP:0002028) | 2.75366437 |
| 59 | Abnormality of the nasal mucosa (HP:0000433) | 2.73033194 |
| 60 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.70635340 |
| 61 | Arterial thrombosis (HP:0004420) | 2.64448151 |
| 62 | Meningitis (HP:0001287) | 2.63705969 |
| 63 | Anorexia (HP:0002039) | 2.60597375 |
| 64 | Urticaria (HP:0001025) | 2.59189493 |
| 65 | Thick nail (HP:0001805) | 2.59096428 |
| 66 | Polyneuropathy (HP:0001271) | 2.54316766 |
| 67 | Abnormality of T cell physiology (HP:0011840) | 2.53429307 |
| 68 | Recurrent pneumonia (HP:0006532) | 2.53326255 |
| 69 | Combined immunodeficiency (HP:0005387) | 2.52017226 |
| 70 | Severe combined immunodeficiency (HP:0004430) | 2.51887320 |
| 71 | IgA deficiency (HP:0002720) | 2.49832612 |
| 72 | Chronic sinusitis (HP:0011109) | 2.49001645 |
| 73 | Petechiae (HP:0000967) | 2.48185667 |
| 74 | Granulocytopenia (HP:0001913) | 2.44685444 |
| 75 | Thyroiditis (HP:0100646) | 2.43529520 |
| 76 | Nuclear cataract (HP:0100018) | 2.41318037 |
| 77 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.41209041 |
| 78 | Gastrointestinal stroma tumor (HP:0100723) | 2.37641974 |
| 79 | Cellulitis (HP:0100658) | 2.37526905 |
| 80 | Progressive neurologic deterioration (HP:0002344) | 2.37301627 |
| 81 | Keratoconjunctivitis (HP:0001096) | 2.36774690 |
| 82 | Glomerulonephritis (HP:0000099) | 2.36765693 |
| 83 | Pulmonary embolism (HP:0002204) | 2.34265762 |
| 84 | Recurrent lower respiratory tract infections (HP:0002783) | 2.33563974 |
| 85 | Keratoconjunctivitis sicca (HP:0001097) | 2.33092147 |
| 86 | Gangrene (HP:0100758) | 2.32982842 |
| 87 | Parakeratosis (HP:0001036) | 2.30036568 |
| 88 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.29391921 |
| 89 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.29391921 |
| 90 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.29391921 |
| 91 | Thrombocytosis (HP:0001894) | 2.28584239 |
| 92 | Poor head control (HP:0002421) | 2.27455844 |
| 93 | Agammaglobulinemia (HP:0004432) | 2.27068504 |
| 94 | Abnormality of the pericardium (HP:0001697) | 2.24534250 |
| 95 | Purpura (HP:0000979) | 2.24419543 |
| 96 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.22526370 |
| 97 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.21529109 |
| 98 | Hematochezia (HP:0002573) | 2.19474720 |
| 99 | Abnormality of B cell number (HP:0010975) | 2.19304859 |
| 100 | Increased serum ferritin (HP:0003281) | 2.18992099 |
| 101 | Mucopolysacchariduria (HP:0008155) | 2.18886228 |
| 102 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.18886228 |
| 103 | Abnormality of the pleura (HP:0002103) | 2.18669513 |
| 104 | Prostate neoplasm (HP:0100787) | 2.17061790 |
| 105 | Amaurosis fugax (HP:0100576) | 2.15056770 |
| 106 | Chest pain (HP:0100749) | 2.14970924 |
| 107 | B lymphocytopenia (HP:0010976) | 2.14764572 |
| 108 | Cleft eyelid (HP:0000625) | 2.14700632 |
| 109 | Nausea (HP:0002018) | 2.11969079 |
| 110 | Upper motor neuron abnormality (HP:0002127) | 2.11302070 |
| 111 | Osteolytic defects of the hand bones (HP:0009699) | 2.10920241 |
| 112 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.10920241 |
| 113 | Increased IgE level (HP:0003212) | 2.10119314 |
| 114 | Personality changes (HP:0000751) | 2.09515237 |
| 115 | Hypoplasia of the thymus (HP:0000778) | 2.09170813 |
| 116 | Increased cerebral lipofuscin (HP:0011813) | 2.07438019 |
| 117 | Skin ulcer (HP:0200042) | 2.06798754 |
| 118 | Emphysema (HP:0002097) | 2.05051888 |
| 119 | Hepatosplenomegaly (HP:0001433) | 2.04983593 |
| 120 | Arthralgia (HP:0002829) | 2.04660351 |
| 121 | Memory impairment (HP:0002354) | 2.04338715 |
| 122 | Premature loss of primary teeth (HP:0006323) | 2.03398271 |
| 123 | Diminished motivation (HP:0000745) | 2.02771041 |
| 124 | Abnormality of the basal ganglia (HP:0002134) | 2.01805611 |
| 125 | Generalized aminoaciduria (HP:0002909) | 2.01649113 |
| 126 | Vertigo (HP:0002321) | 2.01608190 |
| 127 | Lymphopenia (HP:0001888) | 2.01551376 |
| 128 | Abnormality of the endocardium (HP:0004306) | 2.00632959 |
| 129 | Progressive external ophthalmoplegia (HP:0000590) | 2.00567724 |
| 130 | Vertebral compression fractures (HP:0002953) | 2.00503034 |
| 131 | Abnormality of the prostate (HP:0008775) | 1.99912704 |
| 132 | Glomerulopathy (HP:0100820) | 1.99806249 |
| 133 | Myocardial infarction (HP:0001658) | 1.98463456 |
| 134 | Inflammation of the large intestine (HP:0002037) | 1.97775496 |
| 135 | Encephalitis (HP:0002383) | 1.97721703 |
| 136 | Cheilitis (HP:0100825) | 1.95915973 |
| 137 | Keratitis (HP:0000491) | 1.94801360 |
| 138 | Apathy (HP:0000741) | 1.94627241 |
| 139 | Osteomyelitis (HP:0002754) | 1.94288120 |
| 140 | Hypertensive crisis (HP:0100735) | 1.93645836 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 5.29767521 |
| 2 | TYK2 | 4.11287703 |
| 3 | IKBKE | 3.83412025 |
| 4 | TBK1 | 3.79454503 |
| 5 | JAK3 | 3.75263267 |
| 6 | TXK | 3.63924847 |
| 7 | PBK | 3.17386238 |
| 8 | IRAK4 | 3.04641816 |
| 9 | JAK1 | 2.87357208 |
| 10 | FGFR4 | 2.83552996 |
| 11 | IKBKB | 2.61912556 |
| 12 | MAP4K1 | 2.50714734 |
| 13 | KIT | 2.36722062 |
| 14 | MAP3K13 | 2.31096760 |
| 15 | TAOK2 | 2.21832131 |
| 16 | RIPK4 | 2.20064732 |
| 17 | BLK | 2.17912618 |
| 18 | PRPF4B | 1.96894948 |
| 19 | IRAK3 | 1.90491109 |
| 20 | PIM2 | 1.88430671 |
| 21 | BMPR2 | 1.79955658 |
| 22 | CHUK | 1.79834456 |
| 23 | DDR2 | 1.76992632 |
| 24 | NEK9 | 1.72334332 |
| 25 | FGFR3 | 1.72139172 |
| 26 | ZAP70 | 1.65136074 |
| 27 | MST4 | 1.62077083 |
| 28 | MAP3K3 | 1.58914770 |
| 29 | CSK | 1.53983120 |
| 30 | SYK | 1.46394542 |
| 31 | EPHA3 | 1.39757165 |
| 32 | ERN1 | 1.39566593 |
| 33 | EPHB1 | 1.31529176 |
| 34 | EIF2AK2 | 1.30365348 |
| 35 | BTK | 1.19494234 |
| 36 | MAP2K3 | 1.17642553 |
| 37 | IRAK1 | 1.15022587 |
| 38 | TAOK1 | 1.14089787 |
| 39 | LCK | 1.13524231 |
| 40 | HCK | 1.12243253 |
| 41 | TAOK3 | 1.12140092 |
| 42 | MAP3K11 | 1.11801812 |
| 43 | JAK2 | 1.08565484 |
| 44 | TEC | 1.05367116 |
| 45 | CDC42BPA | 0.96889022 |
| 46 | RPS6KA4 | 0.95523368 |
| 47 | SMG1 | 0.94323206 |
| 48 | LYN | 0.94301523 |
| 49 | BCR | 0.94186747 |
| 50 | ARAF | 0.88992778 |
| 51 | PIM1 | 0.84455421 |
| 52 | ADRBK2 | 0.82654535 |
| 53 | NLK | 0.81712234 |
| 54 | HIPK2 | 0.81192577 |
| 55 | ERBB3 | 0.76960714 |
| 56 | SIK3 | 0.76613378 |
| 57 | ITK | 0.75867501 |
| 58 | CSF1R | 0.75814493 |
| 59 | STK4 | 0.73025356 |
| 60 | PRKCD | 0.72209427 |
| 61 | MAP2K6 | 0.69100090 |
| 62 | ABL2 | 0.68760405 |
| 63 | TRPM7 | 0.66711873 |
| 64 | PRKCQ | 0.65574989 |
| 65 | TESK1 | 0.64423805 |
| 66 | MST1R | 0.62316405 |
| 67 | CLK1 | 0.59859799 |
| 68 | RIPK1 | 0.59235466 |
| 69 | MAP3K12 | 0.58193552 |
| 70 | TLK1 | 0.56960110 |
| 71 | TNK2 | 0.56958674 |
| 72 | NME2 | 0.56372900 |
| 73 | BMX | 0.56017779 |
| 74 | IRAK2 | 0.55788682 |
| 75 | MAPKAPK3 | 0.55497007 |
| 76 | STK10 | 0.54119242 |
| 77 | MARK3 | 0.51599590 |
| 78 | MAP3K5 | 0.51299227 |
| 79 | MATK | 0.51096555 |
| 80 | MAPK11 | 0.49173147 |
| 81 | ABL1 | 0.47019940 |
| 82 | TESK2 | 0.46065535 |
| 83 | STK24 | 0.45585382 |
| 84 | FLT3 | 0.44584263 |
| 85 | EGFR | 0.42782449 |
| 86 | SCYL2 | 0.41968777 |
| 87 | TRIB3 | 0.41381119 |
| 88 | MAPKAPK2 | 0.41340210 |
| 89 | RPS6KA5 | 0.40464269 |
| 90 | KDR | 0.40439339 |
| 91 | ACVR1B | 0.39960468 |
| 92 | PTK6 | 0.39498424 |
| 93 | PAK4 | 0.39445616 |
| 94 | PIK3CG | 0.39145987 |
| 95 | FES | 0.37647155 |
| 96 | MOS | 0.35897824 |
| 97 | IGF1R | 0.34838263 |
| 98 | LRRK2 | 0.34709077 |
| 99 | MAP3K1 | 0.34056801 |
| 100 | MELK | 0.32811101 |
| 101 | BMPR1B | 0.31715100 |
| 102 | NUAK1 | 0.30937557 |
| 103 | EIF2AK3 | 0.30510559 |
| 104 | GRK7 | 0.27840150 |
| 105 | FGR | 0.27598098 |
| 106 | BCKDK | 0.25347452 |
| 107 | YES1 | 0.24558240 |
| 108 | PDK1 | 0.23872029 |
| 109 | PKN1 | 0.23869117 |
| 110 | MAPK7 | 0.23137335 |
| 111 | RPS6KA1 | 0.20801020 |
| 112 | RPS6KB2 | 0.20070786 |
| 113 | TGFBR2 | 0.19671255 |
| 114 | SIK1 | 0.19479268 |
| 115 | LATS2 | 0.18984370 |
| 116 | INSR | 0.18027359 |
| 117 | DAPK3 | 0.17898671 |
| 118 | MAPK4 | 0.16691649 |
| 119 | SRC | 0.16186945 |
| 120 | FYN | 0.15760043 |
| 121 | MAP3K8 | 0.15379303 |
| 122 | EIF2AK1 | 0.13236296 |
| 123 | MAPK3 | 0.13217292 |
| 124 | GRK6 | 0.12045992 |
| 125 | TIE1 | 0.10354149 |
| 126 | TGFBR1 | 0.09721775 |
| 127 | ATR | 0.08180871 |
| 128 | NEK6 | 0.07872210 |
| 129 | CDK4 | 0.07633176 |
| 130 | PLK4 | 0.07482842 |
| 131 | RPS6KA6 | 0.06977430 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Allograft rejection_Homo sapiens_hsa05330 | 4.63261243 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 4.55773553 |
| 3 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 3.39876954 |
| 4 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.07461791 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.96908315 |
| 6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.90247848 |
| 7 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.84941658 |
| 8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.80407963 |
| 9 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.73725192 |
| 10 | Measles_Homo sapiens_hsa05162 | 2.73680798 |
| 11 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.46111574 |
| 12 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.39408636 |
| 13 | Influenza A_Homo sapiens_hsa05164 | 2.27302104 |
| 14 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.21205105 |
| 15 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.15869370 |
| 16 | Legionellosis_Homo sapiens_hsa05134 | 2.14642401 |
| 17 | Herpes simplex infection_Homo sapiens_hsa05168 | 2.14368301 |
| 18 | African trypanosomiasis_Homo sapiens_hsa05143 | 2.13013200 |
| 19 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.03078561 |
| 20 | Malaria_Homo sapiens_hsa05144 | 1.97558708 |
| 21 | Pertussis_Homo sapiens_hsa05133 | 1.95245665 |
| 22 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.91241503 |
| 23 | Asthma_Homo sapiens_hsa05310 | 1.89039228 |
| 24 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.88714332 |
| 25 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.82979215 |
| 26 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.81137910 |
| 27 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.67775096 |
| 28 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.67116112 |
| 29 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.59916829 |
| 30 | Tuberculosis_Homo sapiens_hsa05152 | 1.58019687 |
| 31 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.52847239 |
| 32 | Viral myocarditis_Homo sapiens_hsa05416 | 1.52305816 |
| 33 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.36992698 |
| 34 | Salmonella infection_Homo sapiens_hsa05132 | 1.29974258 |
| 35 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.29290950 |
| 36 | Apoptosis_Homo sapiens_hsa04210 | 1.27447240 |
| 37 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.26806646 |
| 38 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.25277829 |
| 39 | Hepatitis C_Homo sapiens_hsa05160 | 1.20300305 |
| 40 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.05700405 |
| 41 | Proteasome_Homo sapiens_hsa03050 | 1.05596060 |
| 42 | Hepatitis B_Homo sapiens_hsa05161 | 0.98490730 |
| 43 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.96314637 |
| 44 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.95636766 |
| 45 | Shigellosis_Homo sapiens_hsa05131 | 0.88626258 |
| 46 | Lysosome_Homo sapiens_hsa04142 | 0.86695287 |
| 47 | Phagosome_Homo sapiens_hsa04145 | 0.86165388 |
| 48 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.74280589 |
| 49 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.68928111 |
| 50 | Amoebiasis_Homo sapiens_hsa05146 | 0.67652298 |
| 51 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.66147816 |
| 52 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.60906228 |
| 53 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.60204286 |
| 54 | Prion diseases_Homo sapiens_hsa05020 | 0.58863857 |
| 55 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.58333648 |
| 56 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.56914630 |
| 57 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.55894510 |
| 58 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.55574083 |
| 59 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.51599846 |
| 60 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.49477408 |
| 61 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.47229094 |
| 62 | Other glycan degradation_Homo sapiens_hsa00511 | 0.47188558 |
| 63 | Bladder cancer_Homo sapiens_hsa05219 | 0.46916772 |
| 64 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.44070432 |
| 65 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.43433137 |
| 66 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.41631611 |
| 67 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.40102942 |
| 68 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.36739987 |
| 69 | Galactose metabolism_Homo sapiens_hsa00052 | 0.35708868 |
| 70 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.35702740 |
| 71 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.35513534 |
| 72 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.35138428 |
| 73 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.34922275 |
| 74 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.33267444 |
| 75 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.33091569 |
| 76 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.30964569 |
| 77 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.27860377 |
| 78 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.27667796 |
| 79 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.25917115 |
| 80 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25169011 |
| 81 | HTLV-I infection_Homo sapiens_hsa05166 | 0.24680756 |
| 82 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.23805832 |
| 83 | Sulfur relay system_Homo sapiens_hsa04122 | 0.23785938 |
| 84 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.21919092 |
| 85 | Platelet activation_Homo sapiens_hsa04611 | 0.21841823 |
| 86 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.19984406 |
| 87 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.18792624 |
| 88 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.18703540 |
| 89 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.17150084 |
| 90 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.16253459 |
| 91 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.15596599 |
| 92 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.15419736 |
| 93 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.13840474 |
| 94 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.12773624 |
| 95 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.12042106 |
| 96 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.10353543 |
| 97 | ABC transporters_Homo sapiens_hsa02010 | 0.10013378 |
| 98 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.09541431 |
| 99 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.08404928 |
| 100 | Mineral absorption_Homo sapiens_hsa04978 | 0.07866581 |
| 101 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.07390603 |
| 102 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.07104393 |
| 103 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.04594161 |
| 104 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.04091096 |
| 105 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.03335329 |
| 106 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.02909139 |
| 107 | Insulin resistance_Homo sapiens_hsa04931 | 0.00345120 |
| 108 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.00341792 |
| 109 | VEGF signaling pathway_Homo sapiens_hsa04370 | -0.0705252 |
| 110 | Histidine metabolism_Homo sapiens_hsa00340 | -0.0620457 |
| 111 | Proteoglycans in cancer_Homo sapiens_hsa05205 | -0.0408275 |
| 112 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0351854 |
| 113 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | -0.0285832 |
| 114 | Peroxisome_Homo sapiens_hsa04146 | -0.0270946 |
| 115 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | -0.0085532 |
| 116 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | -0.0068498 |

